Inventor
SONG MOO YOUNG
KR14 patents
⚠️ This page may combine multiple inventors who share the name “SONG MOO YOUNG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
YUHAN CORP
12 patentsUS6680053B2Jan 20, 2004
Variable region of the monoclonal antibody against the HBV S-surface antigen and a gene encoding the same
YUHAN CORP19 citations90
US7645450B2Jan 12, 2010
Humanized antibody specific for tumor necrosis factor-alpha
YUHAN CORP4 citations60
US7112664B2Sep 26, 2006
Variable region of the monoclonal antibody against the HBV S-surface antigen and a gene encoding the same
YUHAN CORP2 citations60
US7109320B2Sep 19, 2006
Nucleic acid molecules encoding human tumor necrosis factor α-specific antibodies
YUHAN CORP2 citations60
US6924368B2Aug 2, 2005
Variable region of the monoclonal antibody against the HBV S-surface antigen and a gene encoding the same
YUHAN CORP3 citations60
US7196177B2Mar 27, 2007
Antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same
YUHAN CORP4 citations59
US11479596B2Oct 25, 2022
Fusion protein comprising thyrotropin receptor variants and use thereof
YUHAN CORP0 citations53
US6939956B2Sep 6, 2005
Variable region of the monoclonal antibody against HBV S-surface antigen and a gene encoding the same
YUHAN CORP0 citations50
US11560416B2Jan 24, 2023
Method for producing dual function proteins and its derivatives
YUHAN CORP0 citations49
US7435414B2Oct 14, 2008
Humanized antibody against S-surface antigen of hepatitis B virus
YUHAN CORP0 citations48
US11505603B2Nov 22, 2022
Anti-TIGIT antibodies and uses thereof
YUHAN CORP0 citations47
US11179440B2Nov 23, 2021
Pharmaceutical composition containing FGF21 mutant fusion protein and method for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis
YUHAN CORP0 citations47